ArticleBMC veterinary research2025
In vitro efficacy of cetyltrimethylammonium bromide (CETAB)-modified nano-montmorillonite against aflatoxin B1 associated toxicity and methanogenesis.
Article in BMC veterinary research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Amino acid-montmorillonite nanocomposites: preparation, characteristics and biological effects on ruminal fermentation and greenhouse gas emission potential in diets exposed to aflatoxin B1 in vitro.Journal of the science of food and agriculture · 2026Article
- Reducing livestock emissions while maintaining productivity in ruminant production systems: challenges and opportunities in the Tropics and the Mediterranean.Tropical animal health and production · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundModified nano-montmorillonite is gaining attention as a feed additive for its benefits on ruminal fermentation. Chemical and mechanical methods were used to modify montmorillonite. Cetyltrimethylammonium bromide (CETAB) was utilized for chemical modification, while grounding was carried out to achieve the desired nanoscale particle size, resulting in the formation of the nanoscale powder known as MNM
resultsThe MNM
conclusionThese findings underscored the anti-methanogenic properties and the favorable impacts of MNM
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.